Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients

被引:23
|
作者
Slimani, Afef [1 ]
Jelassi, Awatef [1 ]
Jguirim, Imen [1 ]
Najah, Mohamed [1 ]
Rebhi, Lamia [2 ]
Omezzine, Asma [2 ]
Maatouk, Faouzi [3 ]
Ben Hamda, Khaldoun [3 ]
Kacem, Maha [4 ]
Rabes, Jean-Pierre [5 ]
Abifadel, Marianne [6 ]
Boileau, Catherine [5 ,7 ]
Rouis, Mustapha [8 ]
Slimane, Mohamed Naceur [1 ]
Varret, Mathilde [7 ]
机构
[1] Fac Med, Unit Res Genet & Biol Factors Atherosclerosis, Monastir 5000, Tunisia
[2] Sahloul Univ Hosp, Dept Biochem, URMSP 28 04, Sousse, Tunisia
[3] Fattouma Bourguiba Hosp, Dept Cardiovasc Dis, Monastir 5000, Tunisia
[4] Farhat Hachad Hosp, Dept Endocrinol, Sousse, Tunisia
[5] Univ Versailles St Quentin En Yvelines, Hop A Pare, AP HP, Versailles, France
[6] Univ St Joseph, Fac Pharm, Beirut, Lebanon
[7] Univ Paris Denis Diderot, CHU Xavier Bichat, INSERM, U698, Paris, France
[8] Univ Paris 06, UMR Physiol & Physiopathol 7079, Paris, France
关键词
Familial hypercholesterolemia; LDLR gene; PCSK9; gene; Phenotypic variability; APOLIPOPROTEIN-E; CHOLESTEROL LEVELS; POLYMORPHISMS; SPECTRUM; VARIANT;
D O I
10.1016/j.atherosclerosis.2012.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autosomal dominant hypercholesterolemia (ADH) is commonly caused by mutations in the low-density lipoprotein (LDL) receptor gene (LDLR), in the apolipoprotein B-100 gene (APOB), or in the proprotein convertase subtilisin kexine 9 gene (PCSK9). ADH subjects carrying a mutation in LDLR present highly variable plasma LDL-cholesterol (LDL-C). This variability might be due to environmental factors or the effect of some modifying genes such as PCSK9 and APOE. Aims: We investigated the molecular basis of thirteen Tunisian ADH families and attempted to determine the impact of PCSK9 and APOE gene variations on LDL-cholesterol levels and on the variable phenotypic expression of the disease. Methods and results: Fifty six subjects were screened for mutations in the LDLR gene through direct sequencing. The causative mutation was found to segregate with the disease in each family and a new frameshift mutation, p.Met767CysfsX21, was identified in one family. The distribution of total-and LDL-cholesterol levels, adjusted for age and gender, among homozygous and heterozygous ADH patients varied widely. Within seven families, nine subjects presented low LDL-cholesterol levels despite carrying a mutation in the LDLR gene. To identify the molecular actors underlying this phenotypic variability, the PCSK9 gene was screened using direct sequencing and/or enzymatic restriction analysis, and the apo E genotypes were determined. A new missense variation (p.Pro174Ser) in the PCSK9 gene was identified and characterized as a new putative loss-of-function mutation. Conclusion: Genetic variations in PCSK9 and APOE genes could explain only part of the variability observed in the phenotypic expression in Tunisian ADH patients carrying mutations in the LDLR gene. Other genetic variants and environmental factors very probably act to fully explain this phenotypic variability. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 50 条
  • [1] Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia
    Pisciotta, Livia
    Oliva, Claudio Priore
    Cefalu, Angelo Baldassare
    Noto, Davide
    Bellocchio, Antonella
    Fresa, Raffaele
    Cantafora, Alfredo
    Patel, Dilip
    Averna, Maurizio
    Tarugi, Patrizia
    Calandra, Sebastiano
    Bertolini, Stefano
    ATHEROSCLEROSIS, 2006, 186 (02) : 433 - 440
  • [2] CHARACTERIZATION OF THE EFFECTS OF FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN LDLR ON PCSK9 BINDING
    Deng, Shijun
    Alabi, Adekunle
    Zhang, Dawei
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 55 - 55
  • [3] Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia
    Huijgen, R.
    Fouchier, S. W.
    Denoun, M.
    Hutten, B. A.
    Vissers, M. N.
    Lambert, G.
    Kastelein, J. J. P.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (05) : 979 - 983
  • [4] Functional Analysis of 3′UTR Variants at the LDLR and PCSK9 Genes in Patients with Familial Hypercholesterolemia
    Otero, Javier Sanguino
    Rodriguez-Jimenez, Carmen
    Mostaza Prieto, Jose
    Rodriguez-Antolin, Carlos
    Carazo Alvarez, Ana
    Arrieta Blanco, Francisco
    Rodriguez-Novoa, Sonia
    HUMAN MUTATION, 2024, 2024
  • [5] The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
    Meshkov, Alexey
    Ershova, Alexandra
    Kiseleva, Anna
    Zotova, Evgenia
    Sotnikova, Evgeniia
    Petukhova, Anna
    Zharikova, Anastasia
    Malyshev, Pavel
    Rozhkova, Tatyana
    Blokhina, Anastasia
    Limonova, Alena
    Ramensky, Vasily
    Divashuk, Mikhail
    Khasanova, Zukhra
    Bukaeva, Anna
    Kurilova, Olga
    Skirko, Olga
    Pokrovskaya, Maria
    Mikova, Valeriya
    Snigir, Ekaterina
    Akinshina, Alexsandra
    Mitrofanov, Sergey
    Kashtanova, Daria
    Makarov, Valentin
    Kukharchuk, Valeriy
    Boytsov, Sergey
    Yudin, Sergey
    Drapkina, Oxana
    GENES, 2021, 12 (01) : 1 - 17
  • [6] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Reddy, Lakshmi Lavanya
    Shah, Swarup A. V.
    Ponde, Chandrashekhar K.
    Dalal, Jamshed J.
    Jatale, Raj G.
    Dalal, Reeta J.
    Rajani, Rajesh M.
    Pillai, Sudhir K.
    Vanjani, Chander V.
    Ashavaid, Tester F.
    JOURNAL OF HUMAN GENETICS, 2021, 66 (10) : 983 - 993
  • [7] PCSK9 analysis in familial hypercholesterolaemia patients negative for LDLR and APOB mutations
    George, P. M.
    Homer, V. M.
    Laurie, A. D.
    Hurndell, N.
    Scott, R. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 135 - 135
  • [8] Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
    Hori, Mika
    Ohta, Naotaka
    Takahashi, Atsushi
    Masuda, Hiroaki
    Isoda, Rieko
    Yamamoto, Suguru
    Son, Cheol
    Ogura, Masatsune
    Hosoda, Kiminori
    Miyamoto, Yoshihiro
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2019, 289 : 101 - 108
  • [9] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Lakshmi Lavanya Reddy
    Swarup A. V. Shah
    Chandrashekhar K. Ponde
    Jamshed J. Dalal
    Raj G. Jatale
    Reeta J. Dalal
    Rajesh M. Rajani
    Sudhir K. Pillai
    Chander V. Vanjani
    Tester F. Ashavaid
    Journal of Human Genetics, 2021, 66 : 983 - 993
  • [10] LDLR, PCSK9, AND LDLRAP1 MUTATIONS IN THE SAME PATIENT IN A FAMILIAL HYPERCHOLESTEROLEMIA (FH) FAMILY
    Cocci, Guido
    Cenci, Alessandra
    Bordicchia, Marica
    Sarzani, Riccardo
    ATHEROSCLEROSIS, 2017, 263 : E232 - E232